OMX Nordic 40
2.435,58
PKT
+16,77
PKT
+0,69
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) neutral | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.05.20 | Hennes Mauritz (H M, H&M) Equal-Weight | Morgan Stanley | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Kepler Cheuvreux | |
| 11.05.20 | Novo Nordisk Neutral | UBS AG | |
| 11.05.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 06.05.20 | Novo Nordisk buy | UBS AG | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.05.20 | Nokia buy | Deutsche Bank AG | |
| 04.05.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.05.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 01.05.20 | Nokia Equal weight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | Nokia Neutral | Credit Suisse Group | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 30.04.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | Nokia buy | UBS AG | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 30.04.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 30.04.20 | AstraZeneca Reduce | HSBC | |
| 29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.20 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. |